NCT03475186 2026-03-13
Testing Ramipril to Prevent Memory Loss in People With Glioblastoma
Wake Forest University Health Sciences
Phase 2 Completed
Clinical Trials
14 trialsNCT07313709 2026-01-02
Measuring the Feasibility and Effect of a Virtual Reality Cognitive Training Intervention for Brain Cancer Survivors.
University of Cincinnati
Phase NA Not yet recruiting
NCT06930846 2025-11-21
HOBSCOTCH-CA
Dartmouth-Hitchcock Medical Center
Phase NA Recruiting
NCT05858359 2025-10-03
ImPACT
Aarhus University Hospital
Phase NA Completed
NCT02670161 2025-08-24
Quality Improvement and Practice Based Research in Neurology Using the EMR
Endeavor Health
Phase 4 Enrolling by invitation
NCT06327048 2025-08-12
Application of Cognitive Training Based on the Remind Strategy in Glioma Patients With Cognitive Impairment
LanZhou University
Phase NA Completed
NCT02360215 2025-04-23
Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases
NRG Oncology
Phase 3 Completed
NCT06043765 2024-11-18
TRUE-GRIT
Amsterdam UMC, location VUmc
Phase NA Recruiting
NCT04395339 2024-08-01
GLORY
Sun Yat-sen University
Phase 3 Terminated
NCT06051240 2024-04-12
LiBRA
Region Stockholm
Phase 2 Recruiting
NCT05321498 2023-09-28
Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation
Inmune Bio, Inc.
Phase 2 Withdrawn
NCT01151670 2018-08-01
Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors
Wake Forest University Health Sciences
Phase 1 Completed
NCT03373487 2018-02-13
Cognitive Rehabilitation in Brain Tumor Patients After Neurosurgery
Elisabeth-TweeSteden Ziekenhuis
Phase NA Unknown
NCT00594633 2016-01-14
Adjunctive Donepezil Therapy and Genetic Risk Factors of Cognitive Dysfunction in Brain Tumor Survivors
Memorial Sloan Kettering Cancer Center
Phase 1 Completed